Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
11:08am, Wednesday, 30'th Jul 2025
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share
08:00am, Wednesday, 30'th Jul 2025
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
01:46pm, Tuesday, 29'th Jul 2025
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging McKesson (MCK) This Year?
10:41am, Tuesday, 29'th Jul 2025
Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
10:31am, Tuesday, 29'th Jul 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
McKesson Defied The Doubters (Including Me)--And Could Do It Again
12:52am, Saturday, 26'th Jul 2025
McKesson delivered strong double-digit growth in revenue, earnings, and free cash flow in fiscal 2025, outperforming the S&P 500 significantly. The planned spin-off of the underperforming Medical-Surg
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 23'rd Jul 2025
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Wednesday, 23'rd Jul 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here's Why McKesson (MCK) is a Strong Value Stock
10:40am, Tuesday, 22'nd Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Our Top 10 High Growth Dividend Stocks - July 2025
08:00am, Saturday, 19'th Jul 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive
08:00am, Tuesday, 15'th Jul 2025
IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson hosted more than 2,500 attendees representing independent pharmacies at the 2025 McKesson ideaShare conference in Nashville.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Thursday, 10'th Jul 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 09'th Jul 2025
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why McKesson (MCK) Dipped More Than Broader Market Today
07:01pm, Tuesday, 08'th Jul 2025
McKesson (MCK) concluded the recent trading session at $724.11, signifying a -1.53% move from its prior day's close.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
10:40am, Friday, 04'th Jul 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
